# Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator

> **NCT04504188** · NA · RECRUITING · sponsor: **Zoll Medical Corporation** · enrollment: 300 (estimated)

## Conditions studied

- Cardiomyopathies
- Heart Failure

## Interventions

- **DEVICE:** Heart Rate Monitor Enhanced Treatment Optimization

## Key facts

- **NCT ID:** NCT04504188
- **Lead sponsor:** Zoll Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-08
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04504188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04504188, "Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04504188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*